HOWL

Werewolf Therapeutics, Inc. HOWL

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode HOWL IOBT SPRB OTLK ACET NRXP LITS OSTX CUE INMB
6M -59.31 % -73.43 % 870.05 % -77.34 % -33.65 % -24.58 % -68.43 % -13.10 % -64.72 % -26.07 %
YTD -14.81 % -25.18 % -18.93 % -17.24 % -6.12 % -13.36 % -7.14 % 8.96 % -10.49 % 12.34 %
1Y -59.01 % -37.94 % 155.93 % -75.06 % -43.71 % -46.71 % -68.43 % -64.56 % -76.41 % -74.26 %
3Y -84.35 % -79.75 % -63.00 % -97.87 % -94.07 % -83.06 % -68.43 % -41.83 % -91.01 % -80.43 %
5Y -96.59 % -96.79 % -95.66 % -97.83 % -96.16 % -99.30 % -68.43 % -41.83 % -97.94 % -93.56 %
10Y -96.59 % -96.79 % -94.23 % -99.92 % -99.56 % -97.64 % -68.43 % -41.83 % -97.40 % -78.35 %
From the beginning -96.59 % -96.79 % -94.23 % -99.92 % -99.56 % -97.64 % -68.43 % -41.83 % -97.40 % -78.35 %

Dividend

Adicet Bio, Inc.

Lite Strategy, Inc.